These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Diagnosis and Management of Fibrotic Interstitial Lung Diseases. Collins BF; Luppi F Clin Chest Med; 2021 Jun; 42(2):321-335. PubMed ID: 34024407 [TBL] [Abstract][Full Text] [Related]
8. The Evolving Concept of the Multidisciplinary Approach in the Diagnosis and Management of Interstitial Lung Diseases. Sanduzzi Zamparelli S; Sanduzzi Zamparelli A; Bocchino M Diagnostics (Basel); 2023 Jul; 13(14):. PubMed ID: 37510180 [TBL] [Abstract][Full Text] [Related]
9. Role of imaging in the diagnosis of diffuse and interstitial lung diseases. Oikonomou A Curr Opin Pulm Med; 2014 Sep; 20(5):517-24. PubMed ID: 25050863 [TBL] [Abstract][Full Text] [Related]
10. Impact of Lung Biopsy Information on Treatment Strategy of Patients with Interstitial Lung Diseases. Tomassetti S; Ravaglia C; Puglisi S; Ryu JH; Colby TV; Cavazza A; Wells AU; Pavone M; Vancheri C; Lavorini F; Matucci-Cerinic M; Rosi E; Luzzi V; Gori L; Rossi G; Donati L; Dubini A; Piciucchi S; Poletti V Ann Am Thorac Soc; 2022 May; 19(5):737-745. PubMed ID: 34739359 [No Abstract] [Full Text] [Related]
11. Rapidly non-ipf progressive fibrosing interstitial lung disease: a phenotype with an ipf-like behavior. Khine N; Mudawi D; Rivera-Ortega P; Leonard C; Chaudhuri N; Margaritopoulos GA Sarcoidosis Vasc Diffuse Lung Dis; 2020; 37(2):231-233. PubMed ID: 33093788 [TBL] [Abstract][Full Text] [Related]
12. [Computed tomography in evaluating the development of different types of pulmonary fibrosis in patients with interstitial lung diseases]. Speranskaya AA; Novikova LN; Baranova OP; Dvorakovskaya IV; Kameneva MY; Amosova NA Vestn Rentgenol Radiol; 2015; (4):5-11. PubMed ID: 26552223 [TBL] [Abstract][Full Text] [Related]
13. Possible value of antifibrotic drugs in patients with progressive fibrosing non-IPF interstitial lung diseases. Torrisi SE; Kahn N; Wälscher J; Sarmand N; Polke M; Lars K; Eichinger M; Heussel CP; Palmucci S; Sambataro FM; Sambataro G; Sambataro D; Vancheri C; Kreuter M BMC Pulm Med; 2019 Nov; 19(1):213. PubMed ID: 31718637 [TBL] [Abstract][Full Text] [Related]
14. Elevated serum Krebs von den Lungen-6 in systemic sclerosis: a marker of lung fibrosis and severity of the disease. Benyamine A; Heim X; Resseguier N; Bertin D; Gomez C; Ebbo M; Harlé JR; Kaplanski G; Rossi P; Bardin N; Granel B Rheumatol Int; 2018 May; 38(5):813-819. PubMed ID: 29455320 [TBL] [Abstract][Full Text] [Related]
15. Circulating lung biomarkers in idiopathic lung fibrosis and interstitial lung diseases associated with connective tissue diseases: Where do we stand? Elhai M; Avouac J; Allanore Y Semin Arthritis Rheum; 2020 Jun; 50(3):480-491. PubMed ID: 32089354 [TBL] [Abstract][Full Text] [Related]